Barmastine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C27H29N7O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UIF43N1HSV, chemically known as 4h-pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-((3-(2-furanylmethyl)-3h-imidazo(4,5-b)pyridin-2-yl)amino)-1-piperidinyl)ethyl)-2-methyl-;(2) 3-(2-(4-((3-furfuryl-3h-imidazo(4,5-b)pyridin-2-yl)amino)piperidino)ethyl)-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-one but generally known as barmastine, which bears US NIH Compound Identifier 71300. European Medicines Agency schedules Barmastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06104MIG. The term BARMASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). BARMASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule barmastine under HS 29349990 and SITC 51579. As of Q4 2014, BARMASTINE remains the US FDA Preferred Term for this commodity. Barmastine bears US NLM identifiers UMLS ID C2346963 and NCI Concept Code C73043. SMILES: O=C1N2C(NC(C1CCN1CCC(NC3N(C4NCCCC4N3)CC3OCCC3)CC1)C)CCCC2.